XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 151 filers reported holding XENON PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 3.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,454,185 | +573.9% | 1,125,708 | +659.5% | 0.11% | +558.8% |
| Q2 2023 | $5,706,008 | -68.4% | 148,208 | -70.6% | 0.02% | -69.6% |
| Q1 2023 | $18,060,493 | -61.1% | 504,624 | -57.2% | 0.06% | -64.6% |
| Q4 2022 | $46,461,315 | -21.5% | 1,178,324 | -28.2% | 0.16% | -33.1% |
| Q3 2022 | $59,207,000 | +115.9% | 1,640,072 | +81.9% | 0.24% | +103.4% |
| Q2 2022 | $27,424,000 | -58.2% | 901,506 | -58.0% | 0.12% | -55.6% |
| Q1 2022 | $65,617,000 | -29.8% | 2,146,450 | -28.3% | 0.26% | -30.0% |
| Q4 2021 | $93,489,000 | +467.7% | 2,992,597 | +177.7% | 0.37% | +418.1% |
| Q3 2021 | $16,469,000 | -2.0% | 1,077,800 | +19.5% | 0.07% | -4.0% |
| Q2 2021 | $16,801,000 | +23.3% | 902,300 | +18.6% | 0.08% | +17.2% |
| Q1 2021 | $13,622,000 | +87.3% | 761,001 | +60.9% | 0.06% | +82.9% |
| Q4 2020 | $7,274,000 | +47.0% | 472,979 | +5.8% | 0.04% | +40.0% |
| Q3 2020 | $4,949,000 | -40.1% | 447,061 | -32.2% | 0.02% | -53.7% |
| Q2 2020 | $8,269,000 | +24.6% | 659,404 | +12.7% | 0.05% | 0.0% |
| Q1 2020 | $6,635,000 | -40.9% | 585,053 | -31.6% | 0.05% | -8.5% |
| Q4 2019 | $11,220,000 | +34.6% | 855,800 | -7.5% | 0.06% | +15.7% |
| Q3 2019 | $8,334,000 | -8.6% | 925,000 | 0.0% | 0.05% | +6.2% |
| Q2 2019 | $9,121,000 | +5.6% | 925,000 | +8.8% | 0.05% | +23.1% |
| Q1 2019 | $8,636,000 | +88.8% | 850,000 | +17.2% | 0.04% | +77.3% |
| Q4 2018 | $4,575,000 | -13.4% | 725,000 | +81.2% | 0.02% | 0.0% |
| Q3 2018 | $5,280,000 | +634.4% | 400,000 | +412.2% | 0.02% | +633.3% |
| Q2 2018 | $719,000 | -52.2% | 78,100 | -74.6% | 0.00% | -50.0% |
| Q1 2018 | $1,505,000 | +71.8% | 307,079 | -1.0% | 0.01% | +50.0% |
| Q4 2017 | $876,000 | -4.3% | 310,179 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $915,000 | -6.3% | 310,179 | 0.0% | 0.00% | -20.0% |
| Q2 2017 | $977,000 | -21.3% | 310,179 | 0.0% | 0.01% | -28.6% |
| Q1 2017 | $1,241,000 | -48.0% | 310,179 | 0.0% | 0.01% | -58.8% |
| Q4 2016 | $2,388,000 | -17.8% | 310,179 | -13.5% | 0.02% | -15.0% |
| Q3 2016 | $2,904,000 | +37.3% | 358,531 | 0.0% | 0.02% | +42.9% |
| Q2 2016 | $2,115,000 | -15.6% | 358,531 | 0.0% | 0.01% | -26.3% |
| Q1 2016 | $2,506,000 | -1.8% | 358,531 | +13.0% | 0.02% | -9.5% |
| Q4 2015 | $2,552,000 | -2.7% | 317,385 | 0.0% | 0.02% | 0.0% |
| Q3 2015 | $2,622,000 | -14.9% | 317,385 | +18.7% | 0.02% | 0.0% |
| Q2 2015 | $3,082,000 | +66.1% | 267,340 | +143.0% | 0.02% | +61.5% |
| Q1 2015 | $1,855,000 | – | 110,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
| ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
| BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
| Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
| COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
| DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
| Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
| Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
| KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
| Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |